Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

Trial Profile

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2014

At a glance

  • Drugs Sevelamer (Primary) ; Calcium acetate; Calcium carbonate
  • Indications Hyperphosphataemia
  • Focus Therapeutic Use
  • Sponsors Chugai Pharma Taiwan
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top